Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBX
3201
DELISTED
Unity Biotechnology
UBX
| $138K | ﹤0.01% |
93,670
+29,088
| +45% | +$42.8K |
|
3202
US Gold Corp
USAU
$213M
| $138K | ﹤0.01% |
23,686
+12,635
| +114% | +$73.4K |
|
3203
Rafael Holdings
RFL
$46.7M
| $137K | ﹤0.01% |
71,517
+4,299
| +6% | +$8.23K |
|
3204
GEN Restaurant Group
GENK
$16.7M
| $137K | ﹤0.01% |
16,200
-18,999
| -54% | -$160K |
|
|
HOOK
3205
DELISTED
HOOKIPA Pharma
HOOK
| $135K | ﹤0.01% |
31,470
+1,245
| +4% | +$5.35K |
|
3206
Perimeter Solutions
PRM
$3.25B
| $135K | ﹤0.01% |
+10,000
| New | +$135K |
|
3207
Solowin Holdings
SWIN
$509M
| $134K | ﹤0.01% |
45,900
+4,600
| +11% | +$13.5K |
|
3208
Alset
AEI
$146M
| $132K | ﹤0.01% |
102,666
+1,400
| +1% | +$1.81K |
|
|
CBIO
3209
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $132K | ﹤0.01% |
7,811
-458
| -6% | -$7.74K |
|
3210
POET Technologies
POET
$484M
| $132K | ﹤0.01% |
+29,640
| New | +$132K |
|
3211
ReWalk Robotics
LFWD
$9.18M
| $130K | ﹤0.01% |
40,006
+500
| +1% | +$1.63K |
|
|
WBTN
3212
WEBTOON Entertainment Inc. Common Stock
WBTN
$1.83B
| $130K | ﹤0.01% |
+11,400
| New | +$130K |
|
3213
Context Therapeutics
CNTX
$75M
| $129K | ﹤0.01% |
66,000
+800
| +1% | +$1.57K |
|
3214
Sensei Biotherapeutics
SNSE
$11.8M
| $129K | ﹤0.01% |
10,779
-410
| -4% | -$4.9K |
|
3215
Daxor
DXR
$55.4M
| $128K | ﹤0.01% |
14,821
-300
| -2% | -$2.6K |
|
3216
Sono-Tek
SOTK
$64.2M
| $127K | ﹤0.01% |
31,500
+700
| +2% | +$2.82K |
|
|
LGO
3217
Largo
LGO
$103M
| $127K | ﹤0.01% |
60,697
+16,797
| +38% | +$35.1K |
|
3218
Aura Biosciences
AURA
$412M
| $127K | ﹤0.01% |
14,200
-57,900
| -80% | -$516K |
|
3219
Enlivex Therapeutics
ENLV
$25.5M
| $126K | ﹤0.01% |
74,789
+3,100
| +4% | +$5.21K |
|
3220
TETRA Technologies
TTI
$644M
| $126K | ﹤0.01% |
40,500
+14,300
| +55% | +$44.3K |
|
3221
Broadway Financial
BYFC
$68M
| $124K | ﹤0.01% |
19,249
+5,200
| +37% | +$33.5K |
|
3222
ESS Tech
GWH
$20.5M
| $124K | ﹤0.01% |
19,560
+6,013
| +44% | +$38K |
|
|
SOHO
3223
Sotherly Hotels
SOHO
$16.2M
| $123K | ﹤0.01% |
101,914
+20,500
| +25% | +$24.8K |
|
3224
Vroom, Inc. Common Stock
VRM
$137M
| $123K | ﹤0.01% |
13,126
| – | – |
|
3225
KALA BIO
KALA
$119M
| $122K | ﹤0.01% |
+21,473
| New | +$122K |
|